GI
DVAX

GAMMA Investing’s Dynavax Technologies DVAX Stock Holding History

GAMMA Investing’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,202
Closed -$33.9K – 4151
2025
Q4 		$33.9K Sell
2,202
-1,265
-36% -$13.9K ﹤0.01% 2311
2025
Q3 		$34.4K Buy
3,467
+188
+6% +$1.96K ﹤0.01% 2225
2025
Q2 		$32.5K Sell
3,279
-4,450
-58% -$46.9K ﹤0.01% 2196
2025
Q1 		$100K Buy
7,729
+3,627
+88% +$48K 0.01% 1255
2024
Q4 		$52.4K Buy
4,102
+1,457
+55% +$17.6K ﹤0.01% 1616
2024
Q3 		$29.5K Buy
2,645
+1,685
+176% +$18.6K ﹤0.01% 1861
2024
Q2 		$10.8K Buy
960
+659
+219% +$7.67K ﹤0.01% 2210
2024
Q1 		$3.73K Buy
301
+66
+28% +$861 ﹤0.01% 2526
2023
Q4 		$3.04K Buy
+235
New +$3.26K ﹤0.01% 2434

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's DVAX Position: Q1 2026 in Review

GAMMA Investing sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 2,202 shares — an estimated $33.9K sold.

GAMMA Investing first reported a position in DVAX in Q4 2023 and held it in 9 quarters. The position peaked at $100K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • GAMMA Investing reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • GAMMA Investing sold 2,202 Dynavax Technologies shares in Q1 2026, an estimated $33.9K.
  • GAMMA Investing first reported a position in Dynavax Technologies in Q4 2023 and held it in 9 quarters.
  • GAMMA Investing's Dynavax Technologies position peaked at $100K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.